Little House Capital LLC Sells 254 Shares of The Procter & Gamble Company (NYSE:PG)

Little House Capital LLC cut its stake in shares of The Procter & Gamble Company (NYSE:PG) by 2.8% during the 4th quarter, Holdings Channel reports. The fund owned 8,694 shares of the company’s stock after selling 254 shares during the period. Little House Capital LLC’s holdings in Procter & Gamble were worth $1,274,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also bought and sold shares of the company. Cerity Partners LLC lifted its stake in shares of Procter & Gamble by 106.2% in the fourth quarter. Cerity Partners LLC now owns 6,134,455 shares of the company’s stock valued at $898,943,000 after buying an additional 3,159,796 shares in the last quarter. Wellington Management Group LLP lifted its stake in shares of Procter & Gamble by 9.4% in the third quarter. Wellington Management Group LLP now owns 35,608,913 shares of the company’s stock valued at $5,193,916,000 after buying an additional 3,047,557 shares in the last quarter. International Assets Investment Management LLC lifted its stake in shares of Procter & Gamble by 13,850.3% in the fourth quarter. International Assets Investment Management LLC now owns 2,747,379 shares of the company’s stock valued at $402,601,000 after buying an additional 2,727,685 shares in the last quarter. Assenagon Asset Management S.A. lifted its stake in shares of Procter & Gamble by 235.8% in the fourth quarter. Assenagon Asset Management S.A. now owns 3,231,032 shares of the company’s stock valued at $473,475,000 after buying an additional 2,268,805 shares in the last quarter. Finally, J.P. Morgan Private Wealth Advisors LLC bought a new position in shares of Procter & Gamble in the third quarter valued at $246,412,000. 65.77% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other Procter & Gamble news, insider Balaji Purushothaman sold 28,369 shares of the business’s stock in a transaction that occurred on Tuesday, April 23rd. The shares were sold at an average price of $161.49, for a total value of $4,581,309.81. Following the completion of the transaction, the insider now owns 11,507 shares of the company’s stock, valued at approximately $1,858,265.43. The transaction was disclosed in a filing with the SEC, which is available through this link. In other news, insider Balaji Purushothaman sold 28,369 shares of the company’s stock in a transaction on Tuesday, April 23rd. The shares were sold at an average price of $161.49, for a total value of $4,581,309.81. Following the completion of the sale, the insider now owns 11,507 shares of the company’s stock, valued at approximately $1,858,265.43. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Gary A. Coombe sold 22,000 shares of the company’s stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $161.32, for a total transaction of $3,549,040.00. Following the completion of the sale, the chief executive officer now directly owns 36,845 shares of the company’s stock, valued at approximately $5,943,835.40. The disclosure for this sale can be found here. Insiders sold a total of 100,865 shares of company stock valued at $16,029,280 in the last quarter. Corporate insiders own 0.17% of the company’s stock.

Procter & Gamble Price Performance

Procter & Gamble stock traded down $1.26 during midday trading on Friday, reaching $161.29. 5,659,784 shares of the stock were exchanged, compared to its average volume of 6,820,118. The company’s fifty day moving average is $159.64 and its 200-day moving average is $153.57. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.48 and a current ratio of 0.69. The firm has a market cap of $380.67 billion, a PE ratio of 26.35, a PEG ratio of 3.27 and a beta of 0.44. The Procter & Gamble Company has a 52 week low of $141.45 and a 52 week high of $164.32.

Procter & Gamble (NYSE:PG) last posted its earnings results on Friday, April 19th. The company reported $1.52 earnings per share for the quarter, topping analysts’ consensus estimates of $1.42 by $0.10. The business had revenue of $20.20 billion for the quarter, compared to analyst estimates of $20.43 billion. Procter & Gamble had a net margin of 18.00% and a return on equity of 33.91%. Procter & Gamble’s revenue was up .6% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.37 EPS. On average, sell-side analysts forecast that The Procter & Gamble Company will post 6.55 EPS for the current year.

Procter & Gamble Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th will be paid a $1.0065 dividend. This represents a $4.03 dividend on an annualized basis and a yield of 2.50%. The ex-dividend date is Thursday, April 18th. This is a boost from Procter & Gamble’s previous quarterly dividend of $0.94. Procter & Gamble’s payout ratio is currently 65.69%.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on PG. Wells Fargo & Company raised their price objective on shares of Procter & Gamble from $162.00 to $170.00 and gave the company an “overweight” rating in a research note on Wednesday, January 24th. Stifel Nicolaus raised their price target on shares of Procter & Gamble from $155.00 to $157.00 and gave the company a “hold” rating in a research report on Wednesday, January 24th. StockNews.com lowered shares of Procter & Gamble from a “buy” rating to a “hold” rating in a research report on Thursday, February 29th. Royal Bank of Canada raised their price target on shares of Procter & Gamble from $156.00 to $157.00 and gave the company a “sector perform” rating in a research report on Wednesday, January 24th. Finally, Raymond James raised their price target on shares of Procter & Gamble from $170.00 to $175.00 and gave the company an “outperform” rating in a research report on Wednesday, January 24th. Seven research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $169.76.

About Procter & Gamble

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.